Contact lens fitting after corneal collagen cross-linking.
Preeji Suderman Mandathara, Parthasarathi Kalaiselvan, Varsha M Rathi...
https://pubmed.ncbi.nlm.nih.gov/31902993Actively Recruiting
Led by University of Aarhus · Updated on 2025-08-24
50
Participants Needed
1
Research Sites
25 weeks
Total Duration
U
University of Aarhus
Lead Sponsor
A
Aarhus University Hospital
Collaborating Sponsor
Researchers are evaluating the effects of two types of rigid gas permeable lenses—corneal (CRGPL) and scleral (SRGPL)—on eye health and visual quality in patients with keratoconus, a condition that causes thinning and irregular shaping of the cornea leading to vision problems. This crossover clinical trial aims to compare subjective experiences like comfort and visual function, as well as objective measures including visual acuity, contrast sensitivity, and higher-order aberrations. The study also examines how each lens type impacts the health of the eye's surface tissues and tear film. Participants will be randomly assigned to wear either the corneal RGP lens (Rose K2) or the scleral RGP lens (Onefit MED) for six weeks, followed by a one-week washout period, then switch to the other lens type for another six weeks. The corneal lens fits within the corneal diameter, while the scleral lens is larger and rests on the conjunctival tissue. Both lenses are designed with flexible parameters to suit individual needs. The study involves detailed eye examinations and measurements during each phase. During the study, participants will undergo various assessments including best corrected visual acuity measured by ETDRS charts, contrast sensitivity, subjective questionnaires on visual function and comfort, and detailed imaging and grading of the cornea, conjunctiva, sclera, and tear film. Higher order aberrations will be measured with specialized aberrometry. Safety and ocular health will be monitored throughout the 13-week study period, including before, during, and after each lens wear phase. Participants will be instructed on proper lens use and care, performing lens wear at home with clinical support.
CONDITIONS
Effect of Corneal and Scleral RGP Lenses on Ocular Health and Visual Quality in Keratoconus
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 13 weeks total, including a 1 week washout period between lens types
Participants will wear two types of rigid gas permeable lenses, corneal and scleral, in a randomized crossover design to compare visual quality and ocular health.
Visits occur at baseline and at the end of each 6-week lens wear period
Total: 1 location
1
Aarhus University Hospital
Aarhus, Denmark, 8200
Actively Recruiting
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Preeji Suderman Mandathara, Parthasarathi Kalaiselvan, Varsha M Rathi...
https://pubmed.ncbi.nlm.nih.gov/31902993Kim Nielsen, Jesper Hjortdal, Ellen Aagaard Nohr...
https://pubmed.ncbi.nlm.nih.gov/17645421Sashia Bak-Nielsen, Cecilia H Ramlau-Hansen, Anders Ivarsen...
https://pubmed.ncbi.nlm.nih.gov/30964230Fatih Ozcura, Sayime Aydin, Mehmet Rami Helvaci
https://pubmed.ncbi.nlm.nih.gov/17972223N Efron, P B Morgan, S S Katsara
https://pubmed.ncbi.nlm.nih.gov/11220037Mette Sejer Sørensen, Susanne Andersen, Gitte Osterby Henningsen...
https://pubmed.ncbi.nlm.nih.gov/21651879Melissa Barnett, Claudine Courey, Daddi Fadel...
https://pubmed.ncbi.nlm.nih.gov/33775380Kun Hwang, Joo Ho Kim
https://pubmed.ncbi.nlm.nih.gov/26102541Alexander Levit, Martin Benwell, Bruce J W Evans
https://pubmed.ncbi.nlm.nih.gov/31924530Miguel Romero-Jiménez, Jacinto Santodomingo-Rubido, Jose Manuel González-Méijome
https://pubmed.ncbi.nlm.nih.gov/23771007